Ohio State University Comprehensive Cancer Center
Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2018-04-18
- Target Recruit Count
- 9
- Registration Number
- NCT00841555
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2018-04-17
- Target Recruit Count
- 11
- Registration Number
- NCT00834678
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors
- First Posted Date
- 2009-01-01
- Last Posted Date
- 2016-04-04
- Target Recruit Count
- 65
- Registration Number
- NCT00816335
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- First Posted Date
- 2008-09-18
- Last Posted Date
- 2019-03-06
- Target Recruit Count
- 11
- Registration Number
- NCT00754923
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease
- First Posted Date
- 2008-09-18
- Last Posted Date
- 2018-07-05
- Target Recruit Count
- 35
- Registration Number
- NCT00754910
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
- First Posted Date
- 2008-08-20
- Last Posted Date
- 2016-02-12
- Target Recruit Count
- 4
- Registration Number
- NCT00738361
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2008-08-07
- Last Posted Date
- 2020-05-18
- Target Recruit Count
- 19
- Registration Number
- NCT00729118
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2008-05-09
- Last Posted Date
- 2018-07-24
- Target Recruit Count
- 33
- Registration Number
- NCT00675259
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Conditions
- Interventions
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2017-08-22
- Target Recruit Count
- 23
- Registration Number
- NCT00624936
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2007-12-07
- Last Posted Date
- 2018-03-12
- Target Recruit Count
- 30
- Registration Number
- NCT00569309
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States